ES458113A1 - Un procedimiento para la obtencion de un virus vivo de her- pes de rinoneumonitis equina. - Google Patents

Un procedimiento para la obtencion de un virus vivo de her- pes de rinoneumonitis equina.

Info

Publication number
ES458113A1
ES458113A1 ES458113A ES458113A ES458113A1 ES 458113 A1 ES458113 A1 ES 458113A1 ES 458113 A ES458113 A ES 458113A ES 458113 A ES458113 A ES 458113A ES 458113 A1 ES458113 A1 ES 458113A1
Authority
ES
Spain
Prior art keywords
virus
live
equine rhinopneumonitis
tissue
introducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES458113A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philips Roxane Inc
Original Assignee
Philips Roxane Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Roxane Inc filed Critical Philips Roxane Inc
Publication of ES458113A1 publication Critical patent/ES458113A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/82—Viral vaccine for equine species, e.g. horses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES458113A 1976-04-23 1977-04-22 Un procedimiento para la obtencion de un virus vivo de her- pes de rinoneumonitis equina. Expired ES458113A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/679,840 US4110433A (en) 1976-04-23 1976-04-23 Equine rhinopneumonitis virus

Publications (1)

Publication Number Publication Date
ES458113A1 true ES458113A1 (es) 1978-03-16

Family

ID=24728588

Family Applications (1)

Application Number Title Priority Date Filing Date
ES458113A Expired ES458113A1 (es) 1976-04-23 1977-04-22 Un procedimiento para la obtencion de un virus vivo de her- pes de rinoneumonitis equina.

Country Status (14)

Country Link
US (1) US4110433A (enExample)
AU (1) AU2454077A (enExample)
BE (1) BE853810A (enExample)
DD (1) DD131762A5 (enExample)
DE (1) DE2717919A1 (enExample)
ES (1) ES458113A1 (enExample)
FR (1) FR2348704A1 (enExample)
GB (1) GB1570732A (enExample)
LU (1) LU77166A1 (enExample)
NL (1) NL7704239A (enExample)
NZ (1) NZ183907A (enExample)
PL (1) PL197579A1 (enExample)
SE (1) SE7704514L (enExample)
SU (1) SU700069A3 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
DE69131984T2 (de) * 1990-08-01 2000-07-06 Research Corp. Technologies, Inc. Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
EP1216054A1 (en) * 1999-09-10 2002-06-26 Akzo Nobel N.V. Equine herpes virus temperature sensitive mutant and live vaccine thereof
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6803041B2 (en) 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
WO2007115059A2 (en) 2006-03-29 2007-10-11 Merial Limited Vaccine against streptococci
CN114214289A (zh) * 2021-12-24 2022-03-22 山东省农业科学院畜牧兽医研究所 一株马冠状病毒ECoV464693及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1692043C3 (de) * 1968-03-06 1979-04-12 Behringwerke Ag, 3550 Marburg Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
SE7704514L (sv) 1977-10-24
NZ183907A (en) 1979-10-25
SU700069A3 (ru) 1979-11-25
NL7704239A (nl) 1977-10-25
DD131762A5 (de) 1978-07-19
PL197579A1 (pl) 1978-09-25
DE2717919A1 (de) 1977-11-03
US4110433A (en) 1978-08-29
LU77166A1 (enExample) 1977-08-12
BE853810A (fr) 1977-10-21
FR2348704A1 (fr) 1977-11-18
AU2454077A (en) 1978-10-26
GB1570732A (en) 1980-07-09

Similar Documents

Publication Publication Date Title
ES458113A1 (es) Un procedimiento para la obtencion de un virus vivo de her- pes de rinoneumonitis equina.
ES497425A0 (es) Un metodo de preparacion de un anticuerpo monoclonal.
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
ES8107025A1 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
ES469937A1 (es) Procedimiento para preparar una nueva cepa del virus de la rabia.
ES439442A1 (es) Procedimiento para producir un virus del herpes felino vivo,atenuado, antigenicamente activo.
ES385968A1 (es) Metodo para producir una vacuna de virus de enfermedad de newcastle muy atenuado.
ES436028A1 (es) Un procedimiento de atenuacion del virus de la rinotraquei- tis viral felina virulenta.
BG33280A3 (bg) Метод за получаване на (2, 2- диметил- 1, 2- хидрохинолин- 4- ил)- метилсулфонова киселина и нейни соли
Tobin The production of antibodies in cotton rats by living and killed poliomyelitis viruses
JPS5246549A (en) Exhaust stack
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
BG36046A3 (en) Method for cultivating basid
ES486579A1 (es) Un procedimiento para preparar una vacuna intra-respiratoria
JPS5252867A (en) Method of collecting fresh water from seawater; etc. by using solar en ergy
ES446396A1 (es) Procedimiento para preparar vacunas estimulantes de la pro- duccion de anticuerpos contra virus.
JPS51128483A (en) Process for cultivating algae using fermentation waste gas
ES390603A1 (es) Un procedimiento para la preparacion de un virus de varice-la vivo.
JPS5444094A (en) Preparation of phospholipase by fermentation
JPS5254019A (en) Method of making biological preparations
Hessami et al. A new outbreak of rinderpest in Iran
ES328757A3 (es) Un procedimiento de produccion de una vacuna atenuada para inmunizar a los cerdos contra el colera.
JPS5399389A (en) Method for producing cellulase
JPS5396379A (en) Peocess for producing microbial cells
JPS51130587A (en) Process for preparing l-malic acid by fermentation method